Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 65 (6-7), 573-95

Discovery and Characterization of Endogenous Cannabinoids


Discovery and Characterization of Endogenous Cannabinoids

B R Martin et al. Life Sci.


The characterization of cannabinoid receptors and signal transduction mechanisms provided the impetus for the searching for endogenous ligands for this system. The result was a family of fatty acid derivatives that interact with cannabinoid receptors to varying degrees. The two ligands that have received the most attention are anandamide (AN) and 2-arachidonolyl-glycerol (Ara-Gl). They are both present in central as well as peripheral tissues. Mechanisms for the synthesis and metabolism of AN have been described. Presently, the physiological stimuli for production and release of AN are unknown. As a result, elucidation of its physiological role remains elusive. However, it seems reasonable to conclude that both AN and 2-Ara-Gl interact with cannabinoid receptors in both peripheral and central tissue to produce a wide range of effects. Administration of these ligands to laboratory animals produce effects that are quite similar to those elicited by delta9-tetrahydrocannabinol (THC), the psychoactive constituent in marijuana. Nevertheless, there are some pharmacological differences between the plant-derived THC and the endogenous cannabinoids that could be due to either pharmadynamic or pharmacokinetics dissimilarities. Extensive structure-activity relationship studies have provided some vital insights into the actions of the endogenous ligands. First and foremost, systematic structural alterations in AN have additional support that it is acting at the cannabinoid receptors in a fashion similar to that of THC. Development of metabolically stable analogs of AN, as well as those with greater receptor affinity, have helped substantiate AN and THC similarities. Nevertheless, pharmacological differences remain between the endogenous and exogenous ligands. Whether these differences are due to the nature of their interaction with the cannabinoid receptors, activation of unique signaling pathways, interactions with non-cannabinoid receptors, or pharmacokinetic considerations remain to be resolved.

Similar articles

  • Biochemistry of the Endogenous Ligands of Cannabinoid Receptors
    V Di Marzo et al. Neurobiol Dis 5 (6 Pt B), 386-404. PMID 9974173. - Review
    In 1992 the discovery of the first endogenous ligand of cannabinoid receptors, anandamide, provided conclusive support to the hypothesis that an "endogenous cannabinoid r …
  • Cannabis: Discrimination of "Internal Bliss"?
    JL Wiley. Pharmacol Biochem Behav 64 (2), 257-60. PMID 10515300. - Review
    The recent discovery of arachidonylethanolamide (anandamide), an endogenous ligand for cannabinoid receptors, and the synthesis of SR141716A, a cannabinoid antagonist sel …
  • Biochemistry and Pharmacology of the Endocannabinoids Arachidonylethanolamide and 2-arachidonylglycerol
    CJ Hillard. Prostaglandins Other Lipid Mediat 61 (1-2), 3-18. PMID 10785538. - Review
    The purpose of this review is to discuss the cellular synthesis and inactivation of two putative endogenous ligands of the cannabinoid receptor, N-arachidonylethanolamine …
  • Cannabinoid Receptors and Their Endogenous Ligands
    T Sugiura et al. J Biochem 132 (1), 7-12. PMID 12097154. - Review
    Delta9-Tetrahydrocannabinol, a major psychoactive component of marijuana, has been shown to interact with specific cannabinoid receptors, thereby eliciting a variety of p …
  • Endocannabinoids
    R Mechoulam et al. Eur J Pharmacol 359 (1), 1-18. PMID 9831287. - Review
    The background knowledge leading to the isolation and identification of anandamide and 2-arachidonoyl glycerol, the principal endocannabinoids is described. The structure …
See all similar articles

Cited by 46 PubMed Central articles

See all "Cited by" articles

Publication types

LinkOut - more resources